Menu
GWAS Study

Genome-wide interaction study of smoking and bladder cancer risk.

Figueroa JD, Han SS, Garcia-Closas M et al.

24662972 PubMed ID
GWAS Study Type
15581 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

FJ
Figueroa JD
HS
Han SS
GM
Garcia-Closas M
BD
Baris D
JE
Jacobs EJ
KM
Kogevinas M
SM
Schwenn M
MN
Malats N
JA
Johnson A
PM
Purdue MP
CN
Caporaso N
LM
Landi MT
PL
Prokunina-Olsson L
WZ
Wang Z
HA
Hutchinson A
BL
Burdette L
WW
Wheeler W
VP
Vineis P
SA
Siddiq A
CV
Cortessis VK
KC
Kooperberg C
CO
Cussenot O
BS
Benhamou S
PJ
Prescott J
PS
Porru S
BH
Bueno-de-Mesquita HB
TD
Trichopoulos D
LB
Ljungberg B
CF
Clavel-Chapelon F
WE
Weiderpass E
KV
Krogh V
DM
Dorronsoro M
TR
Travis R
TA
Tjønneland A
BP
Brenan P
CJ
Chang-Claude J
RE
Riboli E
CD
Conti D
GM
Gago-Dominguez M
SM
Stern MC
PM
Pike MC
VD
Van Den Berg D
YJ
Yuan JM
HC
Hohensee C
RR
Rodabough R
CG
Cancel-Tassin G
RM
Roupret M
CE
Comperat E
CC
Chen C
DV
De Vivo I
GE
Giovannucci E
HD
Hunter DJ
KP
Kraft P
LS
Lindstrom S
CA
Carta A
PS
Pavanello S
AC
Arici C
MG
Mastrangelo G
KM
Karagas MR
SA
Schned A
AK
Armenti KR
HG
Hosain GM
HC
Haiman CA
FJ
Fraumeni JF
CS
Chanock SJ
CN
Chatterjee N
RN
Rothman N
SD
Silverman DT
Chapter II

Abstract

Summary of the research findings

Bladder cancer is a complex disease with known environmental and genetic risk factors. We performed a genome-wide interaction study (GWAS) of smoking and bladder cancer risk based on primary scan data from 3002 cases and 4411 controls from the National Cancer Institute Bladder Cancer GWAS. Alternative methods were used to evaluate both additive and multiplicative interactions between individual single nucleotide polymorphisms (SNPs) and smoking exposure. SNPs with interaction P values < 5 × 10(-) (5) were evaluated further in an independent dataset of 2422 bladder cancer cases and 5751 controls. We identified 10 SNPs that showed association in a consistent manner with the initial dataset and in the combined dataset, providing evidence of interaction with tobacco use. Further, two of these novel SNPs showed strong evidence of association with bladder cancer in tobacco use subgroups that approached genome-wide significance. Specifically, rs1711973 (FOXF2) on 6p25.3 was a susceptibility SNP for never smokers [combined odds ratio (OR) = 1.34, 95% confidence interval (CI) = 1.20-1.50, P value = 5.18 × 10(-) (7)]; and rs12216499 (RSPH3-TAGAP-EZR) on 6q25.3 was a susceptibility SNP for ever smokers (combined OR = 0.75, 95% CI = 0.67-0.84, P value = 6.35 × 10(-) (7)). In our analysis of smoking and bladder cancer, the tests for multiplicative interaction seemed to more commonly identify susceptibility loci with associations in never smokers, whereas the additive interaction analysis identified more loci with associations among smokers-including the known smoking and NAT2 acetylation interaction. Our findings provide additional evidence of gene-environment interactions for tobacco and bladder cancer.

560 European ancestry never smoker cases, 2,442 European ancestry ever smoker cases, 1,406 European ancestry never smoker controls, 3,005 European ancestry ever smoker controls

Chapter III

Study Statistics

Key metrics and study information

15581
Total Participants
GWAS
Study Type
Yes
Replicated
494 European ancestry never smoker cases, 1,927 European ancestry ever smoker cases, 2,257 European ancestry never smoker controls, 3,490 European ancestry ever smoker controls
Replication Participants
European
Ancestry
U.S., Spain, Italy, France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.